LT4122B - The active ingredient of pharmaceutical composition for treating aphtae and stomatitis - Google Patents
The active ingredient of pharmaceutical composition for treating aphtae and stomatitis Download PDFInfo
- Publication number
- LT4122B LT4122B LT96-093A LT96093A LT4122B LT 4122 B LT4122 B LT 4122B LT 96093 A LT96093 A LT 96093A LT 4122 B LT4122 B LT 4122B
- Authority
- LT
- Lithuania
- Prior art keywords
- stomatitis
- active ingredient
- pharmaceutical composition
- dimethylpolysiloxane
- treating
- Prior art date
Links
- 208000003265 stomatitis Diseases 0.000 title claims abstract description 10
- 239000004480 active ingredient Substances 0.000 title claims 3
- 239000008194 pharmaceutical composition Substances 0.000 title claims 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 17
- 208000002399 aphthous stomatitis Diseases 0.000 claims abstract description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 16
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 16
- 239000000839 emulsion Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 5
- 210000002200 mouth mucosa Anatomy 0.000 abstract description 3
- 229960001275 dimeticone Drugs 0.000 abstract 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108010011485 Aspartame Proteins 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- -1 patches Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010064594 Oral mucosa erosion Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4341139A DE4341139C1 (de) | 1993-12-02 | 1993-12-02 | Dimeticon zur Behandlung von Aphthen |
US08/207,066 US5393745A (en) | 1993-12-02 | 1994-03-08 | Method for treating aphthae using dimethylpolysiloxane |
Publications (2)
Publication Number | Publication Date |
---|---|
LT96093A LT96093A (en) | 1996-12-27 |
LT4122B true LT4122B (en) | 1997-03-25 |
Family
ID=25931728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LT96-093A LT4122B (en) | 1993-12-02 | 1996-07-01 | The active ingredient of pharmaceutical composition for treating aphtae and stomatitis |
Country Status (22)
Country | Link |
---|---|
US (1) | US5393745A (ru) |
EP (1) | EP0731706B1 (ru) |
JP (1) | JP3895368B2 (ru) |
AT (1) | ATE192929T1 (ru) |
AU (1) | AU705187B2 (ru) |
BG (1) | BG100687A (ru) |
CA (1) | CA2177961C (ru) |
CZ (1) | CZ158096A3 (ru) |
DE (2) | DE4341139C1 (ru) |
ES (1) | ES2150547T3 (ru) |
HU (1) | HU215930B (ru) |
IL (1) | IL111805A (ru) |
LT (1) | LT4122B (ru) |
MD (1) | MD1504F2 (ru) |
NO (1) | NO962259L (ru) |
NZ (1) | NZ277769A (ru) |
PL (1) | PL314800A1 (ru) |
RU (1) | RU2143906C1 (ru) |
SI (1) | SI9420072A (ru) |
SK (1) | SK70196A3 (ru) |
WO (1) | WO1995015169A1 (ru) |
ZA (1) | ZA949563B (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6100245A (en) * | 1999-09-07 | 2000-08-08 | Mcneil-Ppc, Inc. | Use of simethicone to treat ulcerative colitis |
CN1288730A (zh) * | 1999-09-07 | 2001-03-28 | 麦克内尔-Ppc股份有限公司 | 轻泻组合物 |
US9511016B2 (en) | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
US8784872B2 (en) | 2007-11-19 | 2014-07-22 | Comgenrx, Inc. | Formulation for decreasing tobacco, alcohol, drug or food consumption |
US20090130048A1 (en) * | 2007-11-19 | 2009-05-21 | Oronsky Bryan Todd | Topical Composition for Treating Pain |
RU2464989C2 (ru) * | 2010-11-09 | 2012-10-27 | Государственное образовательное учреждение высшего профессионального образования Иркутский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию | Способ лечения хронического рецидивирующего афтозного стоматита и средство для его осуществления |
RU2444348C1 (ru) * | 2010-11-12 | 2012-03-10 | Александр Иванович Майдан | Способ аппликационного метода грязелечения |
CN104225189A (zh) * | 2014-07-24 | 2014-12-24 | 烟台瑞智生物医药科技有限公司 | 一种治疗胃热熏蒸证型经行口糜的中药 |
MX2021005160A (es) | 2018-11-05 | 2021-09-30 | Inspired Mat Solutions Llc | Protector y portador de la piel dermica. |
EP3876904A4 (en) * | 2018-11-05 | 2022-08-10 | Inspired Material Solutions, LLC | ORAL MUCOSAL CARRIER AND PROTECTION |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990007930A1 (de) | 1989-01-19 | 1990-07-26 | Steigerwald Arzneimittelwerk Gmbh | Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1194885A (en) * | 1967-06-16 | 1970-06-17 | Prev Coat Corp | Novel Silicone-Containing Dentifrices |
US3507955A (en) * | 1968-11-25 | 1970-04-21 | Prev Coat Corp | Silicone containing dentifrices |
IT1222309B (it) * | 1987-07-08 | 1990-09-05 | Menarini Sas | Utilizzazione di forme farmaceutiche per uso topico contenenti miocamicina per la terapia delle infezione da germi sensibili alla miocamicina stessa |
NO178843C (no) * | 1988-07-11 | 1996-06-19 | Sspl Sa Safe Sex Prod Licens | Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer |
FR2648346B1 (fr) * | 1989-06-20 | 1993-10-08 | Dana Dominique | Compositions de dentifrice solide |
IL95642A0 (en) * | 1989-09-15 | 1991-06-30 | Pehrom Pharmaceutical Corp | Topical preparations for treatment of ulcers and other lesions |
NO901031L (no) * | 1990-03-05 | 1991-09-06 | Gunnar Roella | Baktericid sammensetning. |
DE4207704A1 (de) * | 1992-03-11 | 1993-09-16 | Knut Dr Fischer | Verwendung von dimeticon |
-
1993
- 1993-12-02 DE DE4341139A patent/DE4341139C1/de not_active Expired - Fee Related
-
1994
- 1994-03-08 US US08/207,066 patent/US5393745A/en not_active Expired - Lifetime
- 1994-11-29 IL IL11180594A patent/IL111805A/en not_active IP Right Cessation
- 1994-12-01 ZA ZA949563A patent/ZA949563B/xx unknown
- 1994-12-02 SK SK701-96A patent/SK70196A3/sk unknown
- 1994-12-02 AT AT95904417T patent/ATE192929T1/de active
- 1994-12-02 MD MD96-0222A patent/MD1504F2/ru unknown
- 1994-12-02 CZ CZ961580A patent/CZ158096A3/cs unknown
- 1994-12-02 SI SI9420072A patent/SI9420072A/sl unknown
- 1994-12-02 DE DE69424563T patent/DE69424563T2/de not_active Expired - Lifetime
- 1994-12-02 PL PL94314800A patent/PL314800A1/xx unknown
- 1994-12-02 NZ NZ277769A patent/NZ277769A/en not_active IP Right Cessation
- 1994-12-02 RU RU96115137A patent/RU2143906C1/ru active
- 1994-12-02 CA CA002177961A patent/CA2177961C/en not_active Expired - Fee Related
- 1994-12-02 AU AU13117/95A patent/AU705187B2/en not_active Ceased
- 1994-12-02 WO PCT/EP1994/004023 patent/WO1995015169A1/en not_active Application Discontinuation
- 1994-12-02 EP EP95904417A patent/EP0731706B1/en not_active Expired - Lifetime
- 1994-12-02 HU HU9601496A patent/HU215930B/hu not_active IP Right Cessation
- 1994-12-02 ES ES95904417T patent/ES2150547T3/es not_active Expired - Lifetime
- 1994-12-02 JP JP51540895A patent/JP3895368B2/ja not_active Expired - Fee Related
-
1996
- 1996-05-31 NO NO962259A patent/NO962259L/no not_active Application Discontinuation
- 1996-07-01 LT LT96-093A patent/LT4122B/lt not_active IP Right Cessation
- 1996-07-01 BG BG100687A patent/BG100687A/bg unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990007930A1 (de) | 1989-01-19 | 1990-07-26 | Steigerwald Arzneimittelwerk Gmbh | Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes |
Also Published As
Publication number | Publication date |
---|---|
US5393745A (en) | 1995-02-28 |
DE69424563T2 (de) | 2001-01-18 |
LT96093A (en) | 1996-12-27 |
EP0731706A1 (en) | 1996-09-18 |
CA2177961A1 (en) | 1995-06-08 |
HU215930B (hu) | 1999-03-29 |
DE69424563D1 (de) | 2000-06-21 |
SI9420072A (en) | 1997-02-28 |
DE4341139C1 (de) | 1995-04-13 |
WO1995015169A1 (en) | 1995-06-08 |
RU2143906C1 (ru) | 2000-01-10 |
AU1311795A (en) | 1995-06-19 |
EP0731706B1 (en) | 2000-05-17 |
CZ158096A3 (en) | 1996-12-11 |
HUT75528A (en) | 1997-05-28 |
IL111805A0 (en) | 1995-01-24 |
CA2177961C (en) | 2007-10-23 |
ES2150547T3 (es) | 2000-12-01 |
NZ277769A (en) | 1999-09-29 |
NO962259L (no) | 1996-06-17 |
PL314800A1 (en) | 1996-09-30 |
ZA949563B (en) | 1995-08-16 |
IL111805A (en) | 1998-09-24 |
MD1504F2 (ru) | 2000-07-31 |
BG100687A (bg) | 1997-01-31 |
NO962259D0 (no) | 1996-05-31 |
JPH09509144A (ja) | 1997-09-16 |
SK70196A3 (en) | 1997-03-05 |
ATE192929T1 (de) | 2000-06-15 |
AU705187B2 (en) | 1999-05-20 |
HU9601496D0 (en) | 1996-08-28 |
JP3895368B2 (ja) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4748022A (en) | Topical composition | |
US4191750A (en) | Method for treating canker sores | |
US6159955A (en) | Use of hyaluronic acid and a NSAID for the manufacture of a medicament for the treatment of mucosal diseases | |
LT4122B (en) | The active ingredient of pharmaceutical composition for treating aphtae and stomatitis | |
US4672074A (en) | Ointment and process for treating skin lesions | |
US4049798A (en) | Method for the treatment of Herpes Simplex | |
US9901555B2 (en) | Treatment of viral infections | |
EP0402208B1 (fr) | Association de vitamine A à dose physiologique et de différents principes actifs ayant une activité thérapeutique | |
ES2199961T3 (es) | Uso de una composicion que contiene fosfato de histamina para la obtencion de un medicamento para el tratamiento local de las inflamaciones o lesiones epiteliales. | |
US3995057A (en) | Ophthalmological method | |
Lalla et al. | Carcinoma of the penis presenting with dermatomyositis | |
Ghosh et al. | Drug-induced Oral Erythema Multiforme: Report of Two Cases with Review of Literature | |
Baxter et al. | Retinoid herpeticum | |
RU2039566C1 (ru) | Способ лечения воспалительных и дистрофических заболеваний слизистых оболочек органов пищеварения | |
US20030114534A1 (en) | Pharmaceutical preparation for apthous ulcers | |
Turner | Etiology, Differential Diagnosis and Treatment of Some of the Commonly Occurring Ulcers of the Oral Cavity (I). | |
Prucksunand et al. | Prevention action of turmeric against HCl-induced gastric necrosis in rat: to verify the mode of action of previous clinical study | |
Mathur | Ocular Complications in Cutaneous Moniliasis | |
GIBBS | Xylocaine (lidocaine) viscous: a topical anesthetic agent of value for the relief of pain associated with oral mucous membrane lesions | |
Drummond et al. | Tubifast bezoar | |
NZ614958B2 (en) | The treatment of viral infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9A | Lapsed patents |
Effective date: 20001202 |